We serve (2R)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-[1-(9H-fluoren-9-ylmethoxycarbonyl)imidazol-4-yl]propanoic acid CAS:200926-18-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
![(2R)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-[1-(9H-fluoren-9-ylmethoxycarbonyl)imidazol-4-yl]propanoic acid](https://a.dearchem.com/uploads/userup/0/15S2240I-La.png)
Chemical Name: (2R)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-[1-(9H-fluoren-9-ylmethoxycarbonyl)imidazol-4-yl]propanoic acid
CAS.NO: 200926-18-7
Molecular Formula:C36H29N3O6
Molecular Weight:599.63200
Synonyms:
Histidine, N,1-bis[(9H-fluoren-9-ylmethoxy)carbonyl]-
N,1-Bis-Fmoc-D-histidine
N,1-Bis[(9H-fluoren-9-ylmethoxy)carbonyl]histidine
Fmoc-D-His(Fmoc)-OH
Physical and Chemical Properties:
Density:1.4±0.1 g/cm3
Boiling point: /
Flash point: /
Refractive index: 1.696
Specification:
Appearance: White Crystalline Powder
Purity:≥98%
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Keep the container tightly closed, put it in a tight dispenser, and store in a cool, dry place.
Application:pharmaceutical intermediates.
Contact us for information like (2R)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-[1-(9H-fluoren-9-ylmethoxycarbonyl)imidazol-4-yl]propanoic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Fmoc-D-His(Fmoc)-OH physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N,1-Bis[(9H-fluoren-9-ylmethoxy)carbonyl]histidine Use and application,(2R)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-[1-(9H-fluoren-9-ylmethoxycarbonyl)imidazol-4-yl]propanoic acid technical grade,usp/ep/jp grade.
Related News: Christopher Coleman, assistant professor of infection immunology at Nottingham University, told Sky News: “They get their name because under the electron microscope there’s a bright ring around the central core of the virus, like the sun essentially.”Veratraldehyde manufacturer Fate Therapeutics’ iPSC product platform is supported by an intellectual property portfolio of over 250 issued patents and 150 pending patent applications.3-((S)-1-tert-butoxycarbonyl-4-oxo-2-pyrrolidinylcarbonyl)-1,3-thiazolidine supplier Fate Therapeutics’ iPSC product platform is supported by an intellectual property portfolio of over 250 issued patents and 150 pending patent applications.2-Fluoro-4-(trifluoromethyl)benzonitrile vendor Fate Therapeutics’ iPSC product platform is supported by an intellectual property portfolio of over 250 issued patents and 150 pending patent applications.Under the terms of the agreement, ICIG will purchase substantially all of the pharmaceutical intermediates business, excluding the drug delivery technologies portion of the business.
